Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04895956 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Intra-sheath vs Extra-sheath Injection for De Quervain's Tenosynovitis

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 6, 2026 (before its estimated September 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary and study completion pushed from Jun 1, 2026 to Sep 1, 2026v10
  2. Primary and study completion dates: Jun 1, 2025 to Jun 1, 2026v9
  3. Primary completion date: Dec 1, 2024 to Jun 1, 2025v8
  4. Primary completion date: Dec 1, 2023 to Dec 1, 2024
    • Study completion date: Jun 1, 2024 to Jun 1, 2025
    v7
  5. Phase: Not applicable to Phase 4
    • Site contact updated
    v6
Show 4 earlier versionsHide 4 earlier versions
  1. Start date changed from estimate of Jan 1, 2022 to Jan 24, 2022v5
  2. Start date: Sep 30, 2021 to Jan 1, 2022v4
  3. Start date: Aug 1, 2021 to Sep 30, 2021v3
  4. Start date: Jun 1, 2021 to Aug 1, 2021v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of the study is to determine whether or not extra-sheath steroid injections are inferior to intra-sheath steroid injections in the treatment of DeQuervain's Tenosynovitis. Patients will be randomized to either the intra-sheath group or the extra-sheath group and their pre-injection level of pain will be assessed using the visual analog scale. Appropriate injections will then be administered by 1 of 3 UC Davis hand surgeons. Six weeks post injection the patients will be reassessed using the visual analog scale and their score at 6 weeks will be compared to their pre-injection score.
Trial Details
NCT Number NCT04895956
Lead Sponsor University of California, Davis
Conditions
(from sponsor)		 De Quervain Tenosynovitis
Related terms De Quervain Disease
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov